An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis

Diseases of the Esophagus

Volumn 21, Issue 5, 2008, Pages 395-401

  Yang, Y F ^a   Li, H ^b   Xu, X Q ^c   Diao, Y T ^c   Fang, X Q ^a   Wang, Y ^a   Zhao, D L ^d   Wu, K ^c   Li, Hui Qing ^c  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d Feicheng People's Hospital   (China)

Author keywords

Basal cell hyperplasia; Dysplasia; Esophageal squamous cell carcinoma; Reverse transcription polymerase chain reaction; Squamous cell carcinoma antigen 2

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; IODINE; MESSENGER RNA; SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 2;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; BIOLOGICAL MONITORING; BLOOD; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CARCINOMA IN SITU; CELL HYPERPLASIA; CHINA; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRINKING BEHAVIOR; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROBABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 48649099398     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00789.x     Document Type: Article

References (38)

1. Yang C S. Research on esophageal cancer in China: A review. Cancer Res 1980; 40: 2633-44.
2. Qiu S L, Yang G R. Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer 1988; 62: 551-7.
3. Yang G R, Oiu S L. Endoscopie surveys in high-risk populations for esophageal cancer in China with special reference to precursors of esophageal cancer. Endoscopy 1987; 19: 91-5.
4. Wang L D, Lipkin M, Oui S L, Yang G R, Yang C S, Newmark H L. Labeling index and labeling distribution of cells in the esophageal epithelium in individuals at increased risk for esophageal cancer in Huixian, China. Cancer Res 1990; 50: 2651-3.
5. Yang C S, Chung R, Ding I. Genesis of esophageal carcinoma. In: Roth J A, Ruckdeschel J C, Weisenburger T H, (eds). Thoracic Oncology. Philadelphia: W.B. Saunders Co, 1989; 305-15.
6. Correa P. Precursors of gastric and esophageal cancer. Cancer 1982; 50: 2554-65.
7. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40: 1621-8.
8. Suminami Y, Kishi F, Sekiguchi K, Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Res Commun 1991; 181: 51-8.
9. Pontisso P, Calabrese F, Benvegnu L et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004; 90: 833-7.
10. Kato H. Squamous cell carcinoma antigen. In: Sell S, (ed.). Serological Cancer Markers. Totowa, NJ: Humana, 1992; 437-51.
11. Duk J M, Groenier K H, de Bruijn H W et al. Pretreatment serum squamous cell carcinoma antigen: A newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol 1996; 14: 111-8.
12. Vassilakopoulos T, Troupis T, Sotiropoulou C et al. Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 2001; 32: 137-44.
13. Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehvaslaiho H, Stenman U H. Detection of squamous-cell carcinoma antigen-expressing tumor cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Int J Cancer 1997; 74: 75-80.
14. Cataltepe S, Schick C, Luke C J et al. Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2. Clin Chim Acta 2000; 295: 107-27.
15. Cataltepe S, Gornstein E R, Schick C et al. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem 2000; 48: 113-22.
16. Uemura Y, Pak S C, Luke C et al. Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. Int J Cancer 2000; 89: 368-77.
17. Chen Q, Qian J S, Jiang Y, Zhang L. Clinical significance on expression of SCC-Ag in squamous cell carcinoma patients. Clin Med J China 2004; 11: 651-2. (Chinese).
18. Nawata S, Murakami A, Hirabayashi K et al. Identification of squamous cell carcinoma antigen-2 in tumor tissue by two-dimensional electrophoresis. Electrophoresis 1999; 20: 614-7.
19. Hamada K, Hanakawa Y, Hashimoto K et al. Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines. Oncol Rep 2001; 8: 347-54.
20. Murakami A, Suminami Y, Sakaguchi Y et al. Specific detection and quantitation of SCC antigen 1 and SCC antigen 2 mRNAs by fluorescence-based asymmetric semi-nested reverse transcription PCR. Tumour Biol 2000; 21: 224-34.
21. Zhang C, Zhang J, Sun R, Feng J, Wei H, Tian Z. Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: Negative regulation of IFNgamma on NK cells. Int Immunopharmacol 2005; 5: 1057-67.
22. Li J Y, Liu B Q, Li G Y, Chen Z J, Sun X I, Rong S D. Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research. Int J Epidemiol 1981; 10: 127-33.
23. Cancer Prevention and Treatment Office of the Health Ministry of China. Death Investigation on Malignant Tumors in China. Beijing: People's Health Publishing House, 1979. (Chinese).
24. Zhao D L, Yang Y D, Chen M H et al. Study on Risk Factors of Esophageal Cancer in Feicheng City. Chin J Cancer Prev Treat 2003; 10: 27-30. (Chinese).
25. Silverman G A, Bartuski A J, Cataltepe S et al. SCCA1 and SCCA2 are proteinase inhibitors that map to the serpin cluster at 18q21.3. Tumour Biol 1998; 19: 480-7.
26. Brioschi P A, Bischof P, Delafosse C, Krauer F. Squamous cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma. Int J Cancer 1991; 47: 376-9.
27. Gaarenstroom K N, Bonfrer J M, Kenter G G et al. Clinical value of pretreatment serum Cytra 21-1, tissue polypeptide antigen and squamous cell carcinoma antigen levels in patients with cervical cancer. Cancer 1995; 76: 807-13.
28. Hong J H, Tsai C S, Chang J T et al. The prognosic significance of pre- and posttreatment SCC levels in patiens with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys 1998; 41: 823-30.
29. Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K, Hasumi K. The value of squamous cell carcinoma antigen as a predictor of nodal metastases in cervical cancer. Gynecol Oncol 1998; 68: 263-6.
30. Duk J M, van Voorst Vader P C, ten Hoor K A, Hollema H, Doeglas H M, de Bruijn H W. Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 1989; 64: 1652-6.
31. Campbell B, De'Ambrosis B. Squamous cell carcinoma antigen in patients with cutaneous disorders. J Am Acad Dermatol 1990; 22: 639-42.
32. Molina R, Filella X, Torres M D et al. SCC antigen measured in malignant and nonmalignant diseases. Clin Chem 1990; 36: 251-4.
33. Ko Y, Grunewald E, Totzke G et al. High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: A model for the analysis of illegitimate gene expression. Oncology 2000; 59: 81-8.
34. Ikonen E, Manninen T, Peltonen L, Syvanen A C. Quantitative determination of rare mRNA species by PCR and solid-phase minisequencing. PCR Meth Appl 1992; 1: 234-40.
35. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman U H. Detection of prostatic cells in peripheral blood: Correlation with serum concentrations of prostate-specific antigen. Clin Chem 1995; 41: 182-6.
36. Buyru N, Tigli H, Duranyildiz D, Dalay N. Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients. Clin Chem Laboratory Med 2006; 44: 538-41.
37. Wang G Q, Wei W Q, Lu N et al. Significance of screening by iodine staining of endoscopic examination in the area of high incidence of esophageal carcinoma. Chin J Cancer 2003; 22: 175-7. (Chinese).
38. Zhao D L, Wang J L, Zhou Y Z, Li H Q. Cancer incidence during 2000-04 year of Feicheng rural area in Shandong. Chin J Cancer Prev Treat 2005; 12: 891-4. (Chinese).